ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients

BACKGROUND: Breast malignancies are the predominant cancer-related cause of death in women. New methods of diagnosis, prognosis and treatment are necessary. Previously, we identified the breast cancer cell surface protein ADAM8 as a marker of poor survival, and a driver of Triple-Negative Breast Can...

Descripción completa

Detalles Bibliográficos
Autores principales: Pianetti, Stefania, Miller, Kathy D., Chen, Hannah H., Althouse, Sandra, Cao, Sha, Michael, Steven J., Sonenshein, Gail E., Mineva, Nora D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422820/
https://www.ncbi.nlm.nih.gov/pubmed/37568162
http://dx.doi.org/10.1186/s12935-023-03024-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422820/
https://www.ncbi.nlm.nih.gov/pubmed/37568162
http://dx.doi.org/10.1186/s12935-023-03024-3

Ejemplares similares